Thank you very much, Mr. Chair.
I had a bunch of questions. I need to go back to this. Maybe this is for Boehringer, and maybe others.
We talk about the importance of drugs in our health care system, the availability of therapeutics. Why does it seem that drug companies have become the big bad wolf in all of this discussion? Why do governments seem to have to push back on pricing all the time? Is there a disconnect? What have we missed over the last number of years?
It's probably best for Madam Beauchemin or Mr. Alibhai.